Panagora Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-214,997
| Closed | -$1.59M | – | 1147 |
|
|
2024
Q4 | $1.59M | Sell |
214,997
-77,098
| -26% | -$571K | 0.01% | 563 |
|
|
2024
Q3 | $2.74M | Sell |
292,095
-69,092
| -19% | -$649K | 0.01% | 476 |
|
|
2024
Q2 | $2.9M | Buy |
361,187
+37,521
| +12% | +$301K | 0.01% | 430 |
|
|
2024
Q1 | $4.8M | Sell |
323,666
-22,524
| -7% | -$334K | 0.03% | 348 |
|
|
2023
Q4 | $2.81M | Buy |
346,190
+12,216
| +4% | +$99.3K | 0.02% | 464 |
|
|
2023
Q3 | $1.52M | Sell |
333,974
-56,120
| -14% | -$255K | 0.01% | 626 |
|
|
2023
Q2 | $2.75M | Buy |
390,094
+296,053
| +315% | +$2.08M | 0.02% | 459 |
|
|
2023
Q1 | $575K | Buy |
+94,041
| New | +$575K | ﹤0.01% | 1068 |
|
|
2021
Q3 | – | Sell |
-3,336
| Closed | -$87K | – | 2038 |
|
|
2021
Q2 | $87K | Hold |
3,336
| – | – | ﹤0.01% | 1939 |
|
|
2021
Q1 | $106K | Buy |
+3,336
| New | +$106K | ﹤0.01% | 1989 |
|
|
2016
Q1 | – | Sell |
-977
| Closed | -$7K | – | 2314 |
|
|
2015
Q4 | $7K | Sell |
977
-10,265
| -91% | -$73.5K | ﹤0.01% | 2232 |
|
|
2015
Q3 | $63K | Buy |
11,242
+6,494
| +137% | +$36.4K | ﹤0.01% | 1935 |
|
|
2015
Q2 | $41K | Buy |
+4,748
| New | +$41K | ﹤0.01% | 2183 |
|